Hypha Labs

Hypha Labs Financial Leverage

The Financial Leverage (Equity Multiplier) of Hypha Labs (FUNI) as of Nov 5, 2026 is -0.19. In the previous year, Financial Leverage (Equity Multiplier) was -0.53 — a change of -63.49% (higher).

Financial Leverage

-0.19

YoY

-63.49%

Last updated:

Financial Leverage (Equity Multiplier) of Hypha Labs is 2025 -0.19 . Financial Leverage (Equity Multiplier) of Hypha Labs was 2024 -0.53 . It decreases by -63.49% higher compared to the previous year.

The Hypha Labs Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.38 USD
Jan 1, 2019
3.18 USD
Jan 1, 2020
-1.64 USD
Jan 1, 2021
-1.79 USD
Jan 1, 2022
-0.56 USD
Jan 1, 2023
-0.75 USD
Jan 1, 2024
-0.53 USD
Jan 1, 2025
-0.19 USD
The Hypha Labs Financial Leverage history
YEARFinancial LeverageYoY
-0.19-63.49%
-0.53-29.25%
-0.75+35.42%
-0.56-68.97%
-1.79+9.16%
-1.64-151.57%
3.18+130.87%
1.38+23.52%
1.12-4.70%
1.17+27.21%
0.92-5.42%
0.97—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hypha Labs Stock analysis

What does Hypha Labs do? Hypha Labs Inc operates through its subsidiary Digipath Labs, Inc., providing cannabis testing services using FDA-compliant equipment to detect contaminants like pesticides, heavy metals, and microbial toxins for growers, dispensaries, and producers. The company offers data analytics and education services alongside testing, targeting cannabis industry stakeholders including patients and end users. Its business model relies on third-party testing contracts from cannabis businesses and data analytics subscriptions, with revenue generated from laboratory services and educational content for industry professionals. Digipath Labs screens medicinal and recreational cannabis for harmful contaminants including residual solvents, moisture, and aflatoxins, serving a range of clients from cultivators to dispensaries. The company's analytics and training services complement its core testing business, creating multiple revenue streams within the cannabis testing sector. Revenue is derived from testing fees, data analytics packages, and educational programs tailored to cannabis industry participants. Hypha Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypha Labs stock

Financial Leverage (Equity Multiplier) of Hypha Labs is -0.19 in 2025.

Financial Leverage (Equity Multiplier) of Hypha Labs changed from -0.53 to -0.19, representing a -63.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Hypha Labs since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Hypha Labs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hypha Labs

All Key Metrics — Hypha Labs